837 related articles for article (PubMed ID: 27612583)
41. Hodgkin's disease survivors more fatigued than the general population.
Loge JH; Abrahamsen AF; Ekeberg O; Kaasa S
J Clin Oncol; 1999 Jan; 17(1):253-61. PubMed ID: 10458240
[TBL] [Abstract][Full Text] [Related]
42. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
43. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
44. Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
von Tresckow B; Plütschow A; Fuchs M; Klimm B; Markova J; Lohri A; Kral Z; Greil R; Topp MS; Meissner J; Zijlstra JM; Soekler M; Stein H; Eich HT; Mueller RP; Diehl V; Borchmann P; Engert A
J Clin Oncol; 2012 Mar; 30(9):907-13. PubMed ID: 22271480
[TBL] [Abstract][Full Text] [Related]
45. Cancer-Related Fatigue and Muscle Quality in Hodgkin's Lymphoma Survivors.
de Lima FD; Bottaro M; de Oliveira Valeriano R; Cruz L; Battaglini CL; Vieira CA; de Oliveira RJ
Integr Cancer Ther; 2018 Jun; 17(2):299-305. PubMed ID: 28617061
[TBL] [Abstract][Full Text] [Related]
46. Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002.
Calaminus G; Dörffel W; Baust K; Teske C; Riepenhausen M; Brämswig J; Flechtner HH; Singer S; Hinz A; Schellong G
Support Care Cancer; 2014 Jun; 22(6):1519-29. PubMed ID: 24415000
[TBL] [Abstract][Full Text] [Related]
47. Quality of life and fatigue in Hodgkin's lymphoma patients.
Miltényi Z; Magyari F; Simon Z; Illés A
Tumori; 2010; 96(4):594-600. PubMed ID: 20968140
[TBL] [Abstract][Full Text] [Related]
48. [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].
Eich HT; Müller RP; Ansén S; Josting A; Engert A; Hansemann K; Pfistner B; Wolf J; Willich N; Diehl V
Rontgenpraxis; 2003; 55(3):114-24. PubMed ID: 15119314
[TBL] [Abstract][Full Text] [Related]
49. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
[TBL] [Abstract][Full Text] [Related]
50. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma.
Hu Y; Wu LH; Guan HJ; Wu SY; Liu LZ; Cai RQ; Xu YJ; Zhang YZ; Sun XF; Zhu J
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):882-888. PubMed ID: 34535201
[TBL] [Abstract][Full Text] [Related]
51. Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions.
Klimm B; Goergen H; Fuchs M; von Tresckow B; Böll B; Meissner J; Glunz A; Diehl V; Eich HT; Engert A; Borchmann P
Ann Oncol; 2013 Dec; 24(12):3070-6. PubMed ID: 24148816
[TBL] [Abstract][Full Text] [Related]
52. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
[TBL] [Abstract][Full Text] [Related]
53. Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.
Daniëls LA; Oerlemans S; Krol AD; van de Poll-Franse LV; Creutzberg CL
Ann Hematol; 2013 Aug; 92(8):1023-32. PubMed ID: 23728609
[TBL] [Abstract][Full Text] [Related]
54. [Quality of life and socio-medical consequences in adolescent and young adult survivors following treatment for Hodgkin's lymphoma].
Semochkin SY; Arshanskaya EG; Sotnikov VM; Rumyantsev AG
Vopr Onkol; 2015; 61(6):972-7. PubMed ID: 26995990
[TBL] [Abstract][Full Text] [Related]
55. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
56. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study.
Zebrack BJ; Zeltzer LK; Whitton J; Mertens AC; Odom L; Berkow R; Robison LL
Pediatrics; 2002 Jul; 110(1 Pt 1):42-52. PubMed ID: 12093945
[TBL] [Abstract][Full Text] [Related]
57. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.
Greil R; Holzner B; Kemmler G; Kopp M; Buchowski A; Oberaigner W; Fritsch E; Dirnhofer S; Rueffer U; Diehl V; Sperner-Unterweger B
Eur J Cancer; 1999 May; 35(5):698-706. PubMed ID: 10505027
[TBL] [Abstract][Full Text] [Related]
58. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
59. A population-based approach to compare patient-reported outcomes of long-term Hodgkin's lymphoma survivors according to trial participation: a joint study from the Patient-Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship registry and European Organisation for Research and Treatment of Cancer.
Thong MSY; Kicinski M; Coens C; Giusti F; van de Poll-Franse L; Bogaerts J; Liu L
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S223-S228. PubMed ID: 28574866
[TBL] [Abstract][Full Text] [Related]
60. Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
Eikeland SA; Smeland KB; Simensen VC; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
Acta Oncol; 2023 Jan; 62(1):80-88. PubMed ID: 36715320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
